Georg Wurschi

10PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Computational physiologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 17, 2026
Survival and patterns of recurrence in patients with nasopharyngeal carcinoma from a non-endemic region-A German multicenter analysis.

|May 27, 2026
Non-Cisplatin Concurrent Systemic Therapy with Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Network Meta-Analysis of Randomized Clinical Trials.

|Feb 18, 2026
Oxaliplatin-induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose-response relationship and impact on quality of life.

Georg W Wurschi, Andreas Hinz, Melanie Schneider

|Oct 29, 2025
CBCT-Based Online Adaptive, Ultra-Hypofractionated Radiotherapy for Prostate Cancer: First Clinical Experiences.

Georg Wurschi, Alexander Voigt, Noreen Murr

|Oct 25, 2025
Quality of life following total neoadjuvant therapy for rectal cancer.

Georg W Wurschi, Markus Diefenhardt, Justus Kaufmann

|Feb 26, 2025
Circulating Epithelial Tumor Cells (CETC/CTC) in Prostate Cancer: Potential Prognostic Marker for the Risk of Recurrence During Radiotherapy.

Dorothea Schott, Monika Pizon, Sonia Drozdz

Pageof 2

Frequent Collaborators

3 joint publications

Maximilian Römer

3 joint publications

Alexander Rühle

3 joint publications

Felix Ehret

3 joint publications

Jan-Niklas Becker